(Q37733542)

22 August 2017

0 references

1 reference

title

Economic burden of multiple sclerosis: a systematic review of the literature (English)

1 reference

22 August 2017

0 references

1 reference

Huseyin Naci

1

1 reference

22 August 2017

Rachael Fleurence

series ordinal

2

1 reference

22 August 2017

Julie Birt

series ordinal

3

1 reference

22 August 2017

Amy Duhig

series ordinal

4

1 reference

22 August 2017

publication date

1 January 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

28

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

363-379

1 reference

https://scigraph.springernature.com/pub.10.2165/11532230-000000000-00000

22 August 2017

exact match

0 references

cites work

Quality of life among persons with multiple sclerosis and their caregivers.

1 reference

https://api.crossref.org/works/10.2165%2F11532230-000000000-00000

Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532230-000000000-00000

Prevalence, expenditures, utilization, and payment for persons with MS in insured populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532230-000000000-00000

How much do persons with Alzheimer's disease cost Medicare?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532230-000000000-00000

A comprehensive assessment of the cost of multiple sclerosis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11532230-000000000-00000

Multiple sclerosis in the UK: service use, costs, quality of life and disability

21 January 2018

1 reference

12 December 2020

Cost analysis of therapy for patients with multiple sclerosis (MS) in Poland

1 reference

12 December 2020

Costs and quality of life for patients with multiple sclerosis in Belgium.

1 reference

12 December 2020

Cost and health related quality of life consequences of multiple sclerosis

1 reference

12 December 2020

An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain.

1 reference

12 December 2020

The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK.

1 reference

12 December 2020

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability

1 reference

12 December 2020

Getting the work done: a qualitative study of individuals with multiple sclerosis

1 reference

12 December 2020

Costs and quality of life of multiple sclerosis in Italy.

1 reference

12 December 2020

The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis.

1 reference

12 December 2020

Health status and health care utilization of multiple sclerosis in Canada.

1 reference

12 December 2020

Multiple sclerosis in Stockholm County. A pilot study of utilization of health-care resources, patient satisfaction with care and impact on family caregivers

1 reference

12 December 2020

Economic note: cost of illness studies

1 reference

12 December 2020

Health status and quality of life of people with multiple sclerosis.

1 reference

12 December 2020

Costs and quality of life of multiple sclerosis in Austria.

1 reference

12 December 2020

The impact of the financial costs of multiple sclerosis on quality of life.

1 reference

12 December 2020

Costs and quality of life of multiple sclerosis in Switzerland.

1 reference

12 December 2020

Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium)

1 reference

12 December 2020

The economic cost of multiple sclerosis in Sweden in 1994.

1 reference

12 December 2020

Cost of managing an episode of relapse in multiple sclerosis in the United States

1 reference

12 December 2020

Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agents

1 reference

12 December 2020

Cost-of-illness studies: a major headache?

1 reference

12 December 2020

Burden of illness of multiple sclerosis: Part I: Cost of illness. The Canadian Burden of Illness Study Group

1 reference

12 December 2020

Costs and quality of life in multiple sclerosis in The Netherlands.

1 reference

12 December 2020

Usefulness of US cost-of-illness studies in healthcare decision making

1 reference

12 December 2020

The natural history of relapses in multiple sclerosis

1 reference

12 December 2020

Burden of illness of multiple sclerosis: Part II: Quality of life. The Canadian Burden of Illness Study Group

1 reference

12 December 2020

Economic consequences of multiple sclerosis for Canadians

1 reference

12 December 2020

The cost of multiple sclerosis in Australia.

1 reference

12 December 2020

Costs and quality of life of multiple sclerosis in Sweden.

1 reference

12 December 2020

Estimation of the cost of MS in Europe: extrapolations from a multinational cost study

1 reference

12 December 2020

Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database

1 reference

12 December 2020

Costs and quality of life of multiple sclerosis in the United Kingdom.

1 reference

12 December 2020

Costs and quality of life of patients with multiple sclerosis in Europe

1 reference

12 December 2020

The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy

1 reference

12 December 2020

Cost of illness studies: what is good about them?

1 reference

12 December 2020

Cost-of-illness studies : a review of current methods.

1 reference

12 December 2020

Costs and quality of life of multiple sclerosis in Spain.

1 reference

12 December 2020

Quality of life and cost of multiple sclerosis

1 reference

12 December 2020

Utilization of health care by patients with multiple sclerosis is based on professional and patient-defined health needs

1 reference

12 December 2020

Gender as a differential indicator of the employment discrimination experiences of Americans with multiple sclerosis.

1 reference

12 December 2020

Comorbidity, socioeconomic status and multiple sclerosis

1 reference

12 December 2020

Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden.

1 reference

12 December 2020

The distribution of the cost of multiple sclerosis in the UK: how do costs vary by illness severity?

1 reference

12 December 2020

Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

1 reference

12 December 2020

Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis

1 reference

12 December 2020

10.2165/11532230-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

22 August 2017

1001695934

0 references

1 reference